FDA head says working with India to improve drug quality, safety

Tags: News
The U.S. Food and Drug Administration is working with Indian regulators to enhance the quality and safety of drugs made there, the FDA's Commissioner Margaret Hamburg said on Tuesday.

Hamburg also urged Indian regulators to work closely with their foreign peers.

Hamburg was speaking to reporters at the end of a visit to India which follows FDA decisions to ban the shipment of drugs to the United States from plants of leading Indian drugmakers including Ranbaxy Laboratories Ltd and Wockhardt Ltd .

During a visit that started on February 10, Hamburg met the Indian drugs regulator and health ministry officials as well as executives of local drugmakers.

EDITORIAL OF THE DAY

  • It’s time to shift sugarcane production to water abundant states of eastern India

    During the 10 years of UPA rule, the country was able to come out of the so-called sugar cycle — two years of surplus followed by two years of defic

FC NEWSLETTER

Stay informed on our latest news!

TODAY'S COLUMNS

Simon J Evenett

VW scandal has lessons for Make in India

In recent years, when it comes to widespread corporate wrongdoing, ...

Zehra Naqvi

Do you seek peace or conflict?

The pursuit of peace se­ems to be one of the ...

Dharmendra Khandal

So, how do we define a 'vermin'?

These days there’s an ongoing debate whether to declare various ...

INTERVIEWS

William D. Green

Chairman & CEO, Accenture